Global Anatomic Pathology Market OverviewThe global anatomic pathology market is poised for a strong growth trajectory, expected to expand at a CAGR of nearly 8% during the forecast period. This ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...
CR in newly diagnosed NPM1-m AML, with 68% (17/25) of CRc responders achieving molecular MRD negativity by central NGS ...
Pillar Biosciences and AstraZeneca today announced an expansion of their existing laboratory access program for NGS-based ...
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...
The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...
The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...
A conditioning regimen free from total body irradiation (TBI) appeared to be just as effective as standard of care (SoC) in a ...
Adaptive Biotechnologies (ADPT) announced growing interventional use of its clonoSEQ test among the 90 abstracts featuring clonoSEQ data at the ...
In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback